BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3994 related articles for article (PubMed ID: 25386066)

  • 1. Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis.
    Tojo R; Suárez A; Clemente MG; de los Reyes-Gavilán CG; Margolles A; Gueimonde M; Ruas-Madiedo P
    World J Gastroenterol; 2014 Nov; 20(41):15163-76. PubMed ID: 25386066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of probiotic administration on the intestinal microbiota, current knowledge and potential applications.
    de Moreno de LeBlanc A; LeBlanc JG
    World J Gastroenterol; 2014 Nov; 20(44):16518-28. PubMed ID: 25469019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune homeostasis, dysbiosis and therapeutic modulation of the gut microbiota.
    Peterson CT; Sharma V; Elmén L; Peterson SN
    Clin Exp Immunol; 2015 Mar; 179(3):363-77. PubMed ID: 25345825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prebiotic effects: metabolic and health benefits.
    Roberfroid M; Gibson GR; Hoyles L; McCartney AL; Rastall R; Rowland I; Wolvers D; Watzl B; Szajewska H; Stahl B; Guarner F; Respondek F; Whelan K; Coxam V; Davicco MJ; Léotoing L; Wittrant Y; Delzenne NM; Cani PD; Neyrinck AM; Meheust A
    Br J Nutr; 2010 Aug; 104 Suppl 2():S1-63. PubMed ID: 20920376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bifidobacteria and Their Health-Promoting Effects.
    Hidalgo-Cantabrana C; Delgado S; Ruiz L; Ruas-Madiedo P; Sánchez B; Margolles A
    Microbiol Spectr; 2017 Jun; 5(3):. PubMed ID: 28643627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal microbiota, diet and health.
    Power SE; O'Toole PW; Stanton C; Ross RP; Fitzgerald GF
    Br J Nutr; 2014 Feb; 111(3):387-402. PubMed ID: 23931069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probiotics in digestive diseases: focus on Lactobacillus GG.
    Pace F; Pace M; Quartarone G
    Minerva Gastroenterol Dietol; 2015 Dec; 61(4):273-92. PubMed ID: 26657927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of immunity and inflammatory gene expression in the gut, in inflammatory diseases of the gut and in the liver by probiotics.
    Plaza-Diaz J; Gomez-Llorente C; Fontana L; Gil A
    World J Gastroenterol; 2014 Nov; 20(42):15632-49. PubMed ID: 25400447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunology and probiotic impact of the newborn and young children intestinal microflora.
    Bezirtzoglou E; Stavropoulou E
    Anaerobe; 2011 Dec; 17(6):369-74. PubMed ID: 21515397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiota abnormalities in inflammatory airway diseases - Potential for therapy.
    Gollwitzer ES; Marsland BJ
    Pharmacol Ther; 2014 Jan; 141(1):32-9. PubMed ID: 23969226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Probiotics in Human Gut Microbiome-Associated Diseases.
    Kim SK; Guevarra RB; Kim YT; Kwon J; Kim H; Cho JH; Kim HB; Lee JH
    J Microbiol Biotechnol; 2019 Sep; 29(9):1335-1340. PubMed ID: 31434172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbiota role in irritable bowel syndrome: New therapeutic strategies.
    Distrutti E; Monaldi L; Ricci P; Fiorucci S
    World J Gastroenterol; 2016 Feb; 22(7):2219-41. PubMed ID: 26900286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
    Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
    World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Inflammatory and Immunomodulatory Effects of Probiotics in Gut Inflammation: A Door to the Body.
    Cristofori F; Dargenio VN; Dargenio C; Miniello VL; Barone M; Francavilla R
    Front Immunol; 2021; 12():578386. PubMed ID: 33717063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiota and host metabolism in liver cirrhosis.
    Usami M; Miyoshi M; Yamashita H
    World J Gastroenterol; 2015 Nov; 21(41):11597-608. PubMed ID: 26556989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal colonisation, microbiota and future probiotics?
    Salminen S; Benno Y; de Vos W
    Asia Pac J Clin Nutr; 2006; 15(4):558-62. PubMed ID: 17077076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New approaches for bacteriotherapy: prebiotics, new-generation probiotics, and synbiotics.
    Patel R; DuPont HL
    Clin Infect Dis; 2015 May; 60 Suppl 2(Suppl 2):S108-21. PubMed ID: 25922396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential impact of gut microbiota on your health:Current status and future challenges.
    Sirisinha S
    Asian Pac J Allergy Immunol; 2016 Dec; 34(4):249-264. PubMed ID: 28042926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut-liver axis and probiotics: their role in non-alcoholic fatty liver disease.
    Paolella G; Mandato C; Pierri L; Poeta M; Di Stasi M; Vajro P
    World J Gastroenterol; 2014 Nov; 20(42):15518-31. PubMed ID: 25400436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
    Halmos T; Suba I
    Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 200.